CNS Pharmaceuticals, Inc.
CNSP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $278 | $305 | $3,693 | $132,995 |
| - Cash | $9,864 | $12,130 | $13,048 | $6,461 |
| + Debt | $31 | $122 | $211 | $326 |
| Enterprise Value | -$9,556 | -$11,703 | -$9,144 | $126,859 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$3,216 | -$2,370 | -$4,294 | -$3,173 |
| % Margin | – | – | – | – |
| Net Income | -$3,218 | -$2,375 | -$4,301 | -$3,176 |
| % Margin | – | – | – | – |
| EPS Diluted | -104.35 | -77.04 | -18.96 | -2.96 |
| % Growth | -35.4% | -306.3% | -540.5% | – |
| Operating Cash Flow | -$2,174 | -$5,343 | -$3,242 | -$5,471 |
| Capital Expenditures | $0 | $0 | $0 | -$4 |
| Free Cash Flow | -$2,174 | -$5,343 | -$3,242 | -$5,475 |